Lean Toward Tocilizumab as an Add-On to Steroids for COVID-19
August 2021
You'll need to apply the latest evidence for IL-6 inhibitors and Janus kinase (JAK) inhibitors to treat hospitalized COVID-19 patients.
Continue to use a steroid for COVID-19 patients on supplemental oxygen. But compare add-on options...and know when to use them.
A large meta-analysis suggests IL-6 inhibitors, mainly tocilizumab (Actemra), decrease mortality in COVID-19 patients receiving supplemental oxygen...and also taking a steroid.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote